Alzheimer's drug Simufilam fails to meet trial expectations, Cassava Sciences stock takes major hit

Expected with high hopes by all those affected by Alzheimer's and investors alike, the Phase 3 trial of Cassava Sciences' proprietary small molecule Simufilam failed to deliver the anticipated results.…

Continue Reading Alzheimer's drug Simufilam fails to meet trial expectations, Cassava Sciences stock takes major hit

Cleo Capital launches cybersecurity accelerator to help undo the ‘crushing burden’ of online threats

Cleo Capital, the early-stage venture fund that counts the AI firm Groq, fintech company Ellevest, and fashion brand Hill House as investments, has announced the launch of a new cybersecurity…

Continue Reading Cleo Capital launches cybersecurity accelerator to help undo the ‘crushing burden’ of online threats

TSMC To Significantly Upscale “CoWoS” Production Within The Upcoming Quarters, Reaching Up To 130,000 Monthly Output By 2026

TSMC is reportedly "rushing" towards improving CoWoS production as the immense demand from the markets starts to gobble up the whole supply chain. TSMC Faces Massive Demand For Its Packaging…

Continue Reading TSMC To Significantly Upscale “CoWoS” Production Within The Upcoming Quarters, Reaching Up To 130,000 Monthly Output By 2026

Ever wanted to hear a saxophone bark? Nvidia just made the 'world’s most flexible sound machine’ that uses AI to blend music, voices and sounds

Nvidia has announced its new Fugatto generative AI audio toolIt can create and mix audio in all kinds of ways, but isn't out yetFugatto promies to create unique sounds, audio…

Continue Reading Ever wanted to hear a saxophone bark? Nvidia just made the 'world’s most flexible sound machine’ that uses AI to blend music, voices and sounds